Estradiol Transdermal Patches 0.05mg/day from Japan
These are transdermal patches delivering 0.05mg of estradiol per day for hormone replacement therapy in menopausal women. They consist of synthetic hormones from heading 2937, mixed with adhesives and permeation enhancers, put up in measured doses for retail sale. Classified under HTS 3004.39.0055 as a mixed hormone product for therapeutic use.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Obtain FDA approval and ensure NDC labeling for prescription hormone products
• Verify hormone content certificates to confirm classification under heading 2937 derivatives
• Avoid misclassification as cosmetics; these are strictly therapeutic transdermal systems